According to Philips Healthcare CEO Frans van Houten, the company is looking forward to scale up its operations in digital health services and is focusing on research in informatics and wearables. In 2014, Philips revealed its plans to confine its focus on healthcare by splitting the company into two and selling off its traditional lighting business. Philips Healthtech is working towards empowering the personalized healthcare segment as the future lies in it. Product offerings under this segment include hardware, software, and services. According to the results of a study conducted by Philips on 25,000 patients, 69% of these patients surveyed wanted access to their own health data and were confident of managing it. Philips may have to compete with IBM, Alphabet (formerly Google), and Apple, which are the largest players of the informatics market. The CEO revealed that acquisitions could be as large as the USD 1.2 billion deal done in 2014 to takeover Volcano Corporation and the company may also pursue smaller deals as well.
Philips Healthcare eager to expand, planning acquisitions worth over USD 1 billion
GHI Analysis1 min read
GHI Analysis
The leading source of MedTech market intelligence in Latin America. Verified data and competitor insights across the key markets in the region. At GHI, we turn hospital data into strategic actions. Our insights help healthcare companies expand by providing accurate, up-to-date information on hospital infrastructure in LATAM and Asia.
Related Posts
Análisis de GHI
Crece el mercado de equipos médicos en Latinoamérica
Crece el mercado de equipos médicos en Latinoamérica
Una infografía gratis que muestra un boom en el mercado latinoamericano
GHI Analysismayo 9, 2018
Análisis GHI
Top hospitals in Argentina
Top hospitals in Argentina
As part of the annual hospital survey, GHI ranks the Top hospitals in Argentina according…
GHI Analysisjunio 3, 2016
News
Brazil: ANVISA recalls Bayer’s Essure due to safety reasons
Brazil: ANVISA recalls Bayer’s Essure due to safety reasons
Brazil’s National health surveillance agency, ANVISA has banned the sale of Essure, a birth control…
GHI Analysismarzo 13, 2017